Trial site
Hospital Virgen del Camino
- 15running trials
- 6closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Obesity11 trials
- Heart failure5 trials
- Atrial fibrillation3 trials
- Stroke3 trials
- Type 2 diabetes3 trials
- Chronic kidney disease1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Familial hypercholesterolaemia1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 320 trials
- Phase 41 trial
- Status
- Not yet recruiting7 trials
- Completed6 trials
- Active, not recruiting5 trials
- Recruiting3 trials
- Lead sponsor
- Eli Lilly and Company4 trials
- Boehringer Ingelheim3 trials
- Novo Nordisk A/S3 trials
- Regeneron Pharmaceuticals3 trials
- Hoffmann-La Roche2 trials
- and 5 more
Running trials
Not yet recruiting
Not yet recruiting
Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes
Recruiting
Recruiting
Recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity5 recruiting
- Heart failure4 recruiting
- Atrial fibrillation2 recruiting
- Stroke2 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
Closed trials
Active, not recruiting
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026